Q. Zhang, Z. Nanshan, S. Dhooria, X. Fu, J. Lin, W. Li, E. Laws, L. Mannent, Yu Wang, V. Li, A. Li, C.‐C. Hu, D. Lederer, R. Abdulai, L. Robinson
{"title":"Dupilumab在亚太地区持续性哮喘患者中的疗效和安全性:一项随机、双盲、安慰剂对照、平行组的3期研究","authors":"Q. Zhang, Z. Nanshan, S. Dhooria, X. Fu, J. Lin, W. Li, E. Laws, L. Mannent, Yu Wang, V. Li, A. Li, C.‐C. Hu, D. Lederer, R. Abdulai, L. Robinson","doi":"10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a4767","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":222112,"journal":{"name":"C31. BIOLOGICS WANT TO RULE THE (ASTHMA) WORLD","volume":"32 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Efficacy and Safety of Dupilumab in Patients With Persistent Asthma From the Asia-Pacific Region: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study\",\"authors\":\"Q. Zhang, Z. Nanshan, S. Dhooria, X. Fu, J. Lin, W. Li, E. Laws, L. Mannent, Yu Wang, V. Li, A. Li, C.‐C. Hu, D. Lederer, R. Abdulai, L. Robinson\",\"doi\":\"10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a4767\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":222112,\"journal\":{\"name\":\"C31. BIOLOGICS WANT TO RULE THE (ASTHMA) WORLD\",\"volume\":\"32 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"C31. BIOLOGICS WANT TO RULE THE (ASTHMA) WORLD\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a4767\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"C31. BIOLOGICS WANT TO RULE THE (ASTHMA) WORLD","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a4767","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Efficacy and Safety of Dupilumab in Patients With Persistent Asthma From the Asia-Pacific Region: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study